Hao Hu

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Venues

Nature communications

Signal transduction and targeted therapy

Journal of medicinal chemistry

Nature chemical biology

Shanghai Institute of Materia Medica Chinese Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Institute of Materia Medica Chinese Academy of Sciences Oct 20 2016

China

Dr.

University of Georgia Jun 01 2013 - Oct 20 2016

United States

Dr.

Publications

Hao Hu, Wei Hu, An-Di Guo, Linhui Zhai, Song Ma, Hui-Jun Nie, Bin-Shan Zhou, Tianxian Liu, Xinglong Jia, Xing Liu, Xuebiao Yao, Min-Jia Tan, Xiao-Hua Chen
Spatiotemporal and direct capturing global substrates of lysine-modifying enzymes in living cells. Nature communications 15 (1) (2024)
Hao Hu, Wei Hu, An-Di Guo, Linhui Zhai, Song Ma, Hui-Jun Nie, Bin-Shan Zhou, Tianxian Liu, Xinglong Jia, Xing Liu, Xuebiao Yao, Min-Jia Tan, Xiao-Hua Chen
Spatiotemporal and direct capturing global substrates of lysine-modifying enzymes in living cells. Nature communications 15 (1) (2024)
Hao Hu, Wei Hu, An-Di Guo, Linhui Zhai, Song Ma, Hui-Jun Nie, Bin-Shan Zhou, Tianxian Liu, Xinglong Jia, Xing Liu, Xuebiao Yao, Min-Jia Tan, Xiao-Hua Chen
Spatiotemporal and direct capturing global substrates of lysine-modifying enzymes in living cells. Nature communications 15 (1) (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (12) (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry (2024)
Wen-Jing Wang, Lixin Gao, Simei Wang, Wensi Huang, Xin-Yu Meng, Hao Hu, Ziqiang Chen, Jingya Sun, Yali Yuan, Yubo Zhou, Xingxing Diao, Ruimin Huang, Jia Li, Xiao-Hua Chen
Discovery of Orally Bioavailable and Potent CDK9 Inhibitors for Targeting Transcription Regulation in Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (12) (2024)
Ying Dong, Hao Hu, Xuan Zhang, Yunkai Zhang, Xin Sun, Han-Lin Wang, Weijuan Kan, Min-Jia Tan, Hong Shi, Yi Zang, Jia Li
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Signal transduction and targeted therapy 8 (1) (2023)
An-Di Guo, Ke-Nian Yan, Hao Hu, Linhui Zhai, Teng-Fei Hu, Haixia Su, Yijia Chi, Jinyin Zha, Yechun Xu, Dongxin Zhao, Xiaojie Lu, Yong-Jiang Xu, Jian Zhang, Min-Jia Tan, Xiao-Hua Chen
Spatiotemporal and global profiling of DNA-protein interactions enables discovery of low-affinity transcription factors. Nature chemistry (2023)
Ying Dong, Hao Hu, Xuan Zhang, Yunkai Zhang, Xin Sun, Han-Lin Wang, Weijuan Kan, Min-Jia Tan, Hong Shi, Yi Zang, Jia Li
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Signal transduction and targeted therapy 8 (1) (2023)
Ying Dong, Hao Hu, Xuan Zhang, Yunkai Zhang, Xin Sun, Han-Lin Wang, Weijuan Kan, Min-Jia Tan, Hong Shi, Yi Zang, Jia Li
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Signal transduction and targeted therapy 8 (1) (2023)
Ying Dong, Hao Hu, Xuan Zhang, Yunkai Zhang, Xin Sun, Han-Lin Wang, Weijuan Kan, Min-Jia Tan, Hong Shi, Yi Zang, Jia Li
Phosphorylation of PHF2 by AMPK releases the repressive H3K9me2 and inhibits cancer metastasis. Signal transduction and targeted therapy 8 (1) (2023)
Quan Liu, Bingbing Hao, Mingya Zhang, Zhiwei Liu, Yuqi Huang, Xiaoxiao Zhao, Hao Hu, Min-Jia Tan, Jun-Yu Xu
An Integrative Proteome-Based Pharmacologic Characterization and Therapeutic Strategy Exploration of SAHA in Solid Malignancies. Journal of proteome research 21 (4) (2022)
Zhimin Huang, Junxing Zhao, Wei Deng, Yingyi Chen, Jialin Shang, Kun Song, Lu Zhang, Chengxiang Wang, Shaoyong Lu, Xiuyan Yang, Bin He, Jinrong Min, Hao Hu, Min-Jia Tan, Jianrong Xu, Qiufen Zhang, Jie Zhong, Xiaoxiang Sun, Zhiyong Mao, Houwen Lin, Mingzhe Xiao, Y Eugene Chin, Hualiang Jiang, Honghua Shen, Ying Xu, Guo-Qiang Chen, Jian Zhang
Reply to: Binding site for MDL-801 on SIRT6. Nature chemical biology 17 (5) (2021)
An-Di Guo, Dan Wei, Hui-Jun Nie, Hao Hu, Chengyuan Peng, Shao-Tong Li, Ke-Nian Yan, Bin-Shan Zhou, Lei Feng, Chao Fang, Min-Jia Tan, Ruimin Huang, Xiao-Hua Chen
Light-induced primary amines and o-nitrobenzyl alcohols cyclization as a versatile photoclick reaction for modular conjugation. Nature communications 11 (1) (2020)
Hao Hu, Wensi Zhao, Mengdi Zhu, Lei Zhao, Linhui Zhai, Jun-Yu Xu, Ping Liu, Min-Jia Tan
LysargiNase and Chemical Derivatization Based Strategy for Facilitating In-Depth Profiling of C-Terminome. Analytical chemistry 91 (22) (2019)

Hao Hu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hao Hu